HISTIDINE-RICH POLYPEPTIDES, ORAL CANDIDIASIS AND AIDS
HISTIDINE-RICH POLYPEPTIDES, ORAL CANDIDIASIS AND AIDS
批准号:
3221078
负责人:
JERRY J POLLOCK
金额:
$15.77万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-03-01 至 1993-02-28
中文摘要
白色念珠菌和机会性酵母菌,通常存在于口腔
英文摘要
Candida albicans, and opportunistic yeast, normally present in the mouth as
a harmless member of the microbial flora, is the most frequently
encountered and most important fungal pathogen in the oral cavity. In HIV
infected individuals, acquisition of oral candidiasis has become an early
indicator of the development of opportunistic infections and AIDS. At
present, little is known about the shift from C. albicans commensalism to
parasitism. An understanding of this shift form the normal to the diseased
state in relation to the regulation of C. albicans in the oral cavity by
nonimmune natural host defense factors represents the long term goal of
this research. Our specific aims will focus upon the family of the
salivary histidine-rich polypeptides (HRPs) which are thought by us to be
the natural antifungal agents of the mouth. Both in vitro and in vivo
studies will be used to accomplish the following: 1) Determine the
structures of each of the six major HRPs. Purification and
characterization of the HRPs from parotid saliva will be achieved by HPLC,
followed by amino acid gas phase sequencing. Structures will be confirmed
through comparison to chemically synthesized peptides. 2) Determine the
structures of the minor breakdown peptides of these six major HRPs. The
specificity of parotid salivary proteolytic enzymes will be assessed
through cationic polyacrylamide gen electrophoresis, HPLC analysis and
amino acid sequencing. 3) Determine the concentration of the major and
minor HRPs in the parotid salivas of normal healthy individuals. HPLC and
immuno-assays will be used to quantitate the HRPs. 4) Determine the
antifungal potency of physiological concentrations of the HRPs and parotid
saliva against C. albicans. Antimicrobial susceptibility testing will
include both blastospore colony forming unit viability and germ tube
development assays. 5) Determine whether the HRPs can kill C. albicans and
other yeast species growing on the denture acrylic surface. A clinical
model system employing denture stomatitis patients has been developed from
testing the antifungal effects of the HRPs at the in vivo level. 6)
Determine the relationship between AIDS, oral candidiasis and the HRPs.
Parotid salivas of HIV-infected individual with and without oral
candidiasis will be analyzed for the HRPs and for antifungal potency. It
is hypothesized that the prevention of oral candidiasis may lead to the
prevention of the development of opportunistic infections and AIDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SMALL INSTRUMENTATION GRANT
-
批准号:3523861
-
项目类别:
-
资助金额:$1.05万
-
财政年份:1993
-
负责人:JERRY J POLLOCK
-
依托单位:
ORAL ANTIFUNGAL NATURAL AND SYNTHETIC HISTIDINE PEPTIDES
-
批准号:3221074
-
项目类别:
-
资助金额:$3.45万
-
财政年份:1986
-
负责人:JERRY J POLLOCK
-
依托单位:
HISTIDINE-RICH POLYPEPTIDES, ORAL CANDIDIASIS AND AIDS
-
批准号:2129827
-
项目类别:
-
资助金额:$16.2万
-
财政年份:1986
-
负责人:JERRY J POLLOCK
-
依托单位:
HISTIDINE-RICH POLYPEPTIDES, ORAL CANDIDIASIS AND AIDS
-
批准号:3221077
-
项目类别:
-
资助金额:$16.14万
-
财政年份:1986
-
负责人:JERRY J POLLOCK
-
依托单位:
ORAL ANTIFUNGAL NATURAL AND SYNTHETIC HISTIDINE PEPTIDES
-
批准号:3221075
-
项目类别:
-
资助金额:$10.39万
-
财政年份:1986
-
负责人:JERRY J POLLOCK
-
依托单位:
ORAL ANTIFUNGAL NATURAL AND SYNTHETIC HISTIDINE PEPTIDES
-
批准号:3221076
-
项目类别:
-
资助金额:$9.68万
-
财政年份:1986
-
负责人:JERRY J POLLOCK
-
依托单位:
ORAL ANTIFUNGAL NATURAL AND SYNTHETIC HISTIDINE PEPTIDES
-
批准号:3221070
-
项目类别:
-
资助金额:$9.3万
-
财政年份:1986
-
负责人:JERRY J POLLOCK
-
依托单位:
HISTIDINE-RICH POLYPEPTIDES, ORAL CANDIDIASIS AND AIDS
-
批准号:3221071
-
项目类别:
-
资助金额:$17.56万
-
财政年份:1986
-
负责人:JERRY J POLLOCK
-
依托单位:
国内基金
海外基金
活性代谢物 OA 调控 Hog1 介导 Candida albicans 死亡
的机制研究
-
批准号:2024JJ6396
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:彭雪玲
-
依托单位: